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Abstract
The 2010 Global Burden of Disease Study estimates
the premature mortality and disability of all major
diseases and injuries. In addition it aims to quantify
the risk that diseases and other factors play in the
aetiology of disease and injuries. Mental disorders and
coronary heart disease are both significant public
health issues due to their high prevalence and
considerable contribution to global disease burden.
For the first time the Global Burden of Disease Study
will aim to assess mental disorders as risk factors for
coronary heart disease. We show here that current
evidence satisfies established criteria for considering
depression as an independent risk factor in
development of coronary heart disease. A dose
response relationship appears to exist and plausible
biological pathways have been proposed. However, a
number of challenges exist when conducting a
rigorous assessment of the literature including
heterogeneity issues, definition and measurement of
depression and coronary heart disease, publication
bias and residual confounding. Therefore, despite
some limitations in the available data, it is now
appropriate to consider major depression as a risk
factor for coronary heart disease in the new Global
Burden of Disease Study.
Background
Mental disorders and coronary heart disease are both
significant public health issues due to their high preva-
lence and considerable contribution to global disease
burden. The 2001 Global Burden of Disease (GBD)
Study ranked unipolar depressive disorders as the third
leading cause of disease burden, rising to first place for
high- and middle-income countries [1]. In spite of this
ranking, the burden of depression may still be underesti-
mated because of inadequate appreciation of the links
between depression and other health conditions, such as
ischemic heart disease [2].
Ischemic heart disease (IHD) is a major cause of dis-
ease burden, ranked fourth globally and second in high-
and middle-income countries [1]. A number of cohort
studies in recent years have contributed to the growing
body of evidence for links between mental disorders and
cardiovascular disease. The largest body of work in this
area has been done on the association between major
depressive disorder (MDD) and coronary heart disease
(CHD), with results implying the existence of a robust
association [3-7].
Establishing whether depression is an independent risk
factor for CHD could have a significant impact on
resource allocation and treatment for both depressive
and some cardiovascular diseases. Previous GBD studies
have included illicit drug use and alcohol use as risk fac-
tors for outcomes as diverse as IHD, stroke, hypertensive
disease, depression, and intentional and unintentional
injury [8]. Mental disorders other than substance abuse
have not been incorporated in GBD studies as risk factors
to-date.
The 2010 GBD Study currently underway http://www.
globalburden.org/ views risk factors in the context of
several criteria: evidence of a causal effect should be
established, but the risk should be not too broadly
defined (for example diet or environment as a whole) or
be too narrow (for example every single fruit and vege-
table or every toxicant in tobacco smoke). There should
be a relatively specific definition of risk factor exposure
and risk factors should be potentially modifiable. Suffi-
cient data on risk factor exposure and risk factor disease
relationships should exist. Finally, protective as well as
hazardous factors should be considered.
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In their 2007 paper, Prince et al outline implications
for health policy and resourcing based on the under-
recognized burden of mental disorders as a risk factor
for other disease [2]. The relationship between depres-
sion and CHD has been well studied and it is reasonable
to consider it for inclusion as a risk factor for CHD in a
GBD study. There have been studies on the relationship
between depression and other disease entities falling
under the umbrella of vascular disease, other than CHD.
These studies, for example on the relationship between
depression and stroke (CVA), fall beyond the scope of
this review. The objective of this paper is to review the
available evidence on the role of depression as an inde-
pendent risk factor in CHD and recommend whether
this evidence base is sufficiently robust to include
depression as an independent risk factor for CHD in the
new GBD Study.
Discussion
Is the Direct Association Between Depression and CHD
Plausible?
Biological Mechanisms
Depression has various direct and indirect biological
effects which may explain its link with cardiovascular
disease. Current evidence suggest that depression may
act through an autonomically-mediated increase in myo-
cardial workload (and thus ischemia), or in ventricular
irritability; diminished beat-to-beat heart rate variability;
or increased atherogenesis, through relatively direct
effects on platelet function or hypercortisolemia-
mediated effects on other cardiovascular risk factors
such as blood pressure or lipid levels [9,10]. Vascular
endothelial dysfunction of the coronary arteries has also
been observed in a number of cohorts of depressed
patients [11].
Depression-related dysregulation of the sympathoadre-
nal system and HPA axis has been observed to cause an
increase in circulating catecholamines and serum corti-
sol resulting in surges in heart rate and blood pressure,
which increases the risk of atherosclerotic plaque rup-
ture and acute coronary thrombosis [11]. High levels of
catecholamines also increase the irritability of the heart
muscle which can lead to ventricular arrhythmias and
modify the function of circulating platelets [9,11].
Increased cortisol levels lead to inflammation, excessive
clotting, metabolic syndrome, induction of hypercholes-
terolemia and hypertryglyceridemia, and injury of vascu-
lar endothelial cells [2,9]. Effects on serotonin
metabolism have also been shown to lead to additional
alteration of cardiac function, increased platelet activity,
and vasoconstriction [2]. Changes in inflammatory
immune response, such as raised inflammatory markers,
may also predict the development of cardiovascular dis-
ease [2,11].
Behavioral Mechanisms
A number of behavioral pathways have been identified
in the link between mental disorders and cardiovascular
disease. Patients who suffer from a mental disorder are
less likely to adopt a healthy lifestyle or to reduce cardi-
ovascular risk factors. Physical activity and diet control
are less frequently undertaken and smoking and alcohol
consumption rates are often higher [2,11-13]. In addi-
tion, obesity has been strongly associated with both car-
diovascular disease and mental disorders such as
depression, bipolar disorder and panic disorder [2].
Adherence to treatment is often less in depressed
patients compared to non-depressed patients [11].
Depressed patients are known to access social services
less frequently and insufficient social support has been
strongly linked to the development of cardiovascular
disease [11].
Temporal Relationship
Establishing the temporal relationship of depression
antecedent to CHD is a challenge. Both depression and
early stages of cardiovascular disease can go undiag-
nosed for a substantial period of time. In addition, the
relationship between depression and CHD appears to be
bi-directional. Increased prevalence of depression post-
cardiac event and its negative prognostic effect on car-
diac patients has been clearly demonstrated [14,15].
Proof of a temporal relationship can be provided by
only including prospective studies in which patients
with previous CHD are excluded from the study, or at
the very least excluded from the analysis. However,
Rugulies and colleagues [5] tested this hypothesis by
pooling effect sizes for all relevant studies and then for
studies which control for sub-threshold CHD by inten-
sive medical examinations at baseline. They report a
small reduction in the effect size (from 1.77 to 1.51) but
it remains statistically significant.
It can further be argued that if sub-threshold CHD
were present at baseline, relative risk (RR) of outcome
would be higher within a short period of time and tail
off with longer follow-up. The literature does not sup-
port this. Data from the John Hopkins Precursors Study
showed that risk of myocardial infarction (MI) after 40
years of follow-up did not differ from risk after only 10
years (RR of 2.12 and 2.1, respectively) [16]. Implications
of these findings are that possible sub-threshold CHD at
baseline does not significantly affect the risk of incident
CHD in depressed samples.
Evidence for Association between Depression and CHD
Several reviews of the association between depression
and incident CHD have been published. Specifically four
meta-analyses have been published, reporting pooled
relative risk for depression and incident CHD between
1.57 and 2.69 [3,5-7]. A further four qualitative reviews
were identified, all reporting a high degree of evidence
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for the role of depression in the development of CHD
[13-15,17]. A number of authors conclude that the risk
of depression on incident CHD may be equal to that of
smoking [6,7,17].
Three other qualitative reviews [9,11,12] document
increased cardiovascular morbidity and mortality in
patients with depressive symptoms or major depression.
A strong suggestion of a dose-response relationship
between depression and CHD was identified [5,7,11,14].
Depression meeting diagnostic criteria was associated
with a higher risk of CHD compared to depressive
symptoms [5,7]. Existence of a dose-response relation-
ship between exposure and outcome supports likelihood
of causation [15].
Association is stronger with MI than more broadly defined
CHD
A comprehensive meta-analysis based on 28 studies
reported a pooled relative risk of 1.60 (95%CI 1.34-1.92)
for MI compared to 1.48 (95%CI 1.29-1.69) and 1.63
(1.26-2.12) for CHD and CVD, respectively [7]. It was
only when the outcome was narrowed to MI alone that
heterogeneity between studies was eliminated. This sug-
gests that classification of outcome (MI), as opposed to
other factors was an important source of heterogeneity
between the studies. An important limitation of this
review is that not all included studies controlled for
CHD at baseline. Yet the implication of this finding is
that the evidence for depression as an independent risk
factor is more consistent for incident MI than for CHD.
Heterogeneity Issues
The literature on depression and cardiovascular disease
displays large heterogeneity. Lack of consistency in
methodology makes the task of comparing studies and
pooling data for meta-analysis difficult and needs to be
carefully considered in any systematic review. For exam-
ple, it has been shown that the prognostic impact of
initial depression increases over time, with higher odds
ratios for mortality post diagnosis of depression in CHD
in studies with longer follow-up periods [18].
Defining and Measuring Depression
For the purposes of the GBD, depressive disorders are
required to meet the Diagnostic and Statistical Manual
of Mental Disorders (DSM) [19] diagnostic criteria for
major depressive disorder (F32-F33) or dysthymic disor-
der (F34.1), or the WHO International Classification of
Diseases (ICD)[20] criteria for depressive disorders
including dysthymia (F32.0-F32.2, F32.8, F33.0-F33.2,
F33.8, F33.9, F34.1).
However, identification and measurement of depres-
sion is complex and the refinement of adequate, quanti-
tative measures is ongoing. Measures of depression used
in published studies range from self-report of mood to
strict adherence to diagnostic criteria, with a myriad of
other surveys and questionnaires somewhere between
and varying on the spectra of reliability and validity
[11,21].
There exists variation in the cut-off values of ‘diagnos-
tic’ scoring within studies which use the same measure-
ment instrument [22-25]. The ability to compare
findings from various studies employing differing mea-
surement methods is therefore compromised. Case iden-
tification according to DSM or ICD criteria is the ideal.
Where a study falls short of this, for example in large
cohort studies, a diagnosis by a clinician or the use of a
measurement tool which has been shown to acceptably
represent DSM or ICD criteria is considered sufficient
for the case ascertainment of depression. Additional
complication comes about by variations in the period of
assessment (for example, depression experienced during
the past-week versus past 12-months).
Defining and Measuring Coronary Heart Disease
CHD is considered to encompass ischemic heart disease,
myocardial infarction and angina, included cases of
ICD-9 codes 410-414 and 429, or ICD-10 codes 120-
125. The WHO criteria for myocardial infarction (MI)
are also accepted. While the term Coronary Heart Dis-
ease was recommended by Tunstall-Pedoe (2001) [26],
many studies dealing with the relationship between
depression and disease of the coronary vessels use alter-
native nomenclature, such as Coronary Artery Disease
(CAD) or Ischemic Heart Disease (IHD). All essentially
refer to the disease process of atherosclerosis of the cor-
onary arteries leading to myocardial infarction and
angina [27].
MI provides a very well defined clinical marker, both
in terms of a clearly definable ‘hard’ endpoint for cardio-
vascular disease [12], as well as a marker in time, allow-
ing temporal correlation between MI and depressed
mood.
Although case-definitions for CHD are clear in theory,
signs of CHD can be very difficult to detect and subcli-
nical in nature. Hence ruling out CHD at baseline and
proving an unbiased etiological relationship is challen-
ging [28]. This is particularly true for angina and it is
for this reason that angina was not accepted as a proxy
for CHD.
Has the Evidence Base Been Affected by Publication Bias?
The possibility of accurately measuring depression as a
risk factor for CHD appears to be hampered by signifi-
cant publication bias. The apparent over-representation
of positive studies showing an increased risk could in
fact be hiding truer lesser risk of CHD in depressed sub-
jects [3].
Is There Residual Uncontrolled Confounding?
Although the obvious confounding variables should be
controlled for as a requirement for inclusion in a
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quantitative review, residual uncontrolled confounding
cannot be ruled out due to the complex nature of the
depression and CHD relationship. For example, a
depressive state may be associated with other CVD risks
such as smoking and other chronic medical conditions.
Reviews of the literature reporting associations between
psychosocial factors and CHD found strength of evidence
for depression as a causative factor to be strong com-
pared to anxiety where the effect was less consistent
[2,15]. A role for anxiety in the development of CHD is
biologically plausible. Anxiety, as with depression, affects
the autonomic regulation of the heart via the hypothala-
mic-pituitary-adrenocorticol (HPA) axis [10,29]. Chronic
over-activation of these systems due to anxiety would
help to explain the increased frequency of cardiovascular
risk factors in patients with anxiety disorders [10].
Reduced heart rate variability in those with anxiety disor-
ders could also involve impaired vagal control [12]. In
the hypertensive state a chronic anxiety disorder may
trigger increased levels of epinephrine and norephinephr-
ine which could also increase the heart rate, total periph-
eral resistance and even increase the circulating fatty
acids [10]. There is significant evidence which links anxi-
ety disorders to sudden cardiac death [30,31]. However,
anxiety has not been associated with myocardial infarc-
tion in these studies [12,31].
While some reviews have found an association
between anxiety and CHD [32], they included fewer of
the primary studies with negative findings than the
review by Kuper et al [15,33]. We have concluded there
is neither strong nor consistent evidence for a causal
association between anxiety disorders and CHD [33].
However, depression and anxiety are strongly co-mor-
bid [34,35]. Hence we need to consider anxiety as a con-
founder in the relationship between depression and
CHD. Given the conclusion above that anxiety disorders
(alone) do not have a proven etiological relationship
with CHD we examined the evidence for the relation-
ship between major depressive disorder and CHD con-
trolling for other mental disorders. In one study the
odds ratio (OR) for incident MI was only slightly
reduced once phobia, panic disorder and alcohol use/
dependence were controlled for (4.16 95%CI 1.49-11.62
compared to 4.54 95%CI 1.65-12.44) [36]. We therefore
concluded that there is insufficient evidence for co-mor-
bid anxiety substantially mediating the relationship
between depression and CHD.
A number of studies have reported an association
between use of anti-depressant medication and fatal and
nonfatal CHD [37,38]. This raises the issue as to
whether anti-depressant medication, rather than depres-
sion, is a risk factor in development of CHD. A limita-
tion of many earlier papers considering the role of
antidepressants and CHD [37,38] is that few controlled
for the presence of depression or other mental disor-
ders. More recent studies examining depression and
CHD have controlled for the use of medications. Retro-
spective analysis of a primary care sample with IHD
found that use, dose and duration of tricyclic anti-
depressant consumption were not statistically significant
in the development of ischemic heart disease when diag-
nosis and duration of depression were included in the
regression model [39]. In a prospective follow-up of the
Baltimore Epidemiologic Catchment Area reported use
of psychotropic medication had a marginal effect on the
RR of incident MI in a depressed sample (RR 4.16 com-
pared to 4.14) [36].
Summary
Should major depression be considered an independant
etiological risk factor in the development of CHD for
global burden of disease estimates?
There is strong evidence that major depression is an
independent risk factor for CHD. The evidence for this
has emerged recently and this field is still being actively
explored. Studies of the relationship between major
depression and CHD frequently have significant differ-
ences in their methodology and there are potential
biases which may have affected study outcomes.
Several potential confounders such as smoking,
weight, physical activity, blood pressure and cholesterol
[40] have led to controversy over of the effect size mea-
sured in some studies. However, when confounders are
accounted for MDD remains strongly associated with at
least a doubling in risk of cardiac events over 1 to 2
years after an MI [41].
There is sufficient evidence to recommend that Burden
of Disease estimates should include MDD as a risk factor
for CHD, and this evidence is strongest for CHD result-
ing in MI. There are now several large-scale studies from
different countries and settings which have reported con-
sistent findings. We conclude the association between
MDD and CHD is very unlikely to be due to chance or
bias [11]. We agree with Goldston and Baillie [11] that
the existence of several plausible pathophysiological
mechanisms for the relationship, the strength and consis-
tency of the association and the finding that it is dose-
related supports the conclusion that depression is an
independent etiological risk factor in CHD.
What is needed is further research to clarify the nat-
ure of this relationship and specifically to further quan-
tify it. Issues surrounding methodological heterogeneity
could be addressed by adopting standard methodologies.
Some such standards have already been published
[42,43]. It is vital however that further awareness is
raised about major depression as a risk factor for CHD.
We believe the inclusion of major depression as a risk
factor for CHD in the 2010 GBD study will raise
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awareness about the relationship and encourage the col-
lection of international data for more accurate ascertain-
ment of the risk. Given that major depression has
emerged as a risk factor which confers an only slightly
less attributable risk than that of lifetime smoking and a
comparable attributable risk to that of both hyperten-
sion and obesity [4], such action is warranted.
In a broader context, there is also an urgent need for
further well-designed and targeted research examining
other mental disorders as independent risk factors for
cardiovascular disease. Specific areas identified where
future research is needed:
• More and better quality studies with attention to
improved methodological consistencies,
• Examination of risk by country and region - more
research in low- and middle-income countries,
• Clearer understanding of behavioral and biological
pathways and interrelationship of different factors,
• Further validation of and consistencies between
measurement instruments,
• Differentiating between the effects of depression,
anxiety and substance use disorders in the develop-
ment of CHD,
• The impact that pharmacological and/or non-phar-
macological treatment of depression has on CHD
outcomes.
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